AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Managing Intermediate-Risk Pulmonary Embolism
This chapter explores the management strategies for intermediate-risk pulmonary embolism patients, focusing on the shift from unfractionated heparin to low molecular weight heparin due to its safety and ease of use. It discusses scenarios for anticoagulant use, particularly emphasizing oxygenation strategies for critically ill patients and the complexities of fluid therapy. The conversation highlights best practices and emphasizes the need for flexibility and careful assessment in treatment approaches.